NOVONIX (NASDAQ:NVX) Stock Price Down 3.7% - Time to Sell?

Key Points

• NOVONIX shares fell about 3.7% intraday to $0.6550 (low $0.6410) on volume of ~558,316 shares, roughly 25% above the average, and the stock sits below its 50‑day ($0.89) and 200‑day ($1.21) moving averages.
• Analyst sentiment is negative — Weiss Ratings reaffirmed a sell, Wall Street Zen downgraded to a sell, and the MarketBeat consensus rating is Sell.
• The company reported a quarterly EPS of -$0.22 on $1.4 million revenue, sell‑side analysts forecast ~-0.44 EPS for the year, and institutional ownership is very low at 0.06%.

NOVONIX Limited Sponsored ADR (NASDAQ:NVX - Get Free Report)'s share price was down 3.7% during mid-day trading on Monday . The company traded as low as $0.6410 and last traded at $0.6550. Approximately 558,316 shares were traded during mid-day trading, an increase of 25% from the average daily volume of 445,181 shares. The stock had previously closed at $0.68.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of NOVONIX in a research report on Thursday, January 22nd. Wall Street Zen downgraded shares of NOVONIX from a "hold" rating to a "sell" rating in a report on Saturday, March 7th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of "Sell".

NOVONIX Price Performance

The company has a quick ratio of 1.04, a current ratio of 1.07 and a debt-to-equity ratio of 0.23. The company has a fifty day moving average price of $0.89 and a two-hundred day moving average price of $1.21.

NOVONIX (NASDAQ:NVX - Get Free Report) last released its earnings results on Thursday, January 29th. The company reported ($0.22) earnings per share (EPS) for the quarter. The company had revenue of $1.40 million during the quarter. As a group, sell-side analysts forecast that NOVONIX Limited Sponsored ADR will post -0.44 EPS for the current fiscal year.

Institutional Investors Weigh In On NOVONIX

Several large investors have recently made changes to their positions in the stock. GK Wealth Management LLC bought a new position in shares of NOVONIX in the fourth quarter valued at $26,000. OLD Mission Capital LLC acquired a new position in NOVONIX during the fourth quarter worth $32,000. Southeast Asset Advisors LLC bought a new stake in NOVONIX during the third quarter worth $35,000. Susquehanna International Group LLP acquired a new stake in NOVONIX in the third quarter valued at $65,000. Finally, XY Capital Ltd acquired a new stake in NOVONIX in the fourth quarter valued at $66,000. Institutional investors and hedge funds own 0.06% of the company's stock.

About NOVONIX

NOVONIX, trading under the NASDAQ ticker NVX, is a technology-driven company specializing in the development and production of advanced materials and testing solutions for the lithium-ion battery industry. The company's primary focus lies in supplying high-purity synthetic graphite anode materials and delivering comprehensive battery testing services to original equipment manufacturers (OEMs), research institutions, and battery producers worldwide. NOVONIX operates through two core divisions: NOVONIX Materials & Technology, which produces battery-grade graphite, and NOVONIX Battery Testing Solutions, which offers hardware and software platforms designed to accelerate battery research and development.

The Materials & Technology business segment manufactures spherical synthetic graphite anode products that meet rigorous industry standards for performance, consistency, and scalability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.